ATE284879T1 - Indazol-derivate als 5-ht1f agonists - Google Patents
Indazol-derivate als 5-ht1f agonistsInfo
- Publication number
- ATE284879T1 ATE284879T1 AT99305915T AT99305915T ATE284879T1 AT E284879 T1 ATE284879 T1 AT E284879T1 AT 99305915 T AT99305915 T AT 99305915T AT 99305915 T AT99305915 T AT 99305915T AT E284879 T1 ATE284879 T1 AT E284879T1
- Authority
- AT
- Austria
- Prior art keywords
- indazole derivatives
- ht1f agonists
- ht1f
- agonists
- mammal
- Prior art date
Links
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical class C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 title 1
- 102100036311 5-hydroxytryptamine receptor 1F Human genes 0.000 title 1
- 101710138086 5-hydroxytryptamine receptor 1F Proteins 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 206010015866 Extravasation Diseases 0.000 abstract 1
- 101000941893 Felis catus Leucine-rich repeat and calponin homology domain-containing protein 1 Proteins 0.000 abstract 1
- 101150039275 Htr1f gene Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000036251 extravasation Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9494098P | 1998-07-31 | 1998-07-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE284879T1 true ATE284879T1 (de) | 2005-01-15 |
Family
ID=22248060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99305915T ATE284879T1 (de) | 1998-07-31 | 1999-07-26 | Indazol-derivate als 5-ht1f agonists |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6133290A (de) |
| EP (1) | EP0978514B1 (de) |
| AT (1) | ATE284879T1 (de) |
| AU (1) | AU4696199A (de) |
| DE (1) | DE69922594T2 (de) |
| WO (1) | WO2000006173A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6696439B1 (en) * | 1999-02-26 | 2004-02-24 | Eli Lilly And Company | 5-HT1F agonists |
| AU2002255263B2 (en) | 2001-04-16 | 2006-12-14 | Eisai R&D Management Co., Ltd. | Novel 1H-indazole compound |
| US7199147B2 (en) | 2001-06-12 | 2007-04-03 | Dainippon Sumitomo Pharma Co., Ltd. | Rho kinase inhibitors |
| GB0203811D0 (en) * | 2002-02-18 | 2002-04-03 | Glaxo Group Ltd | Compounds |
| BRPI0409211A (pt) * | 2003-04-18 | 2006-03-28 | Lilly Co Eli | composto, composição farmacêutica, métodos para ativar receptores 5-ht1f, para inibir extravasão de proteìna neuronial, e para o tratamento ou prevenção de enxaqueca em um mamìfero, e, uso de um composto |
| EP1676841A1 (de) * | 2004-12-30 | 2006-07-05 | Esteve Laboratorios Dr. Esteve S.A. | Substituierte Indazolsulfonamid- und 2,3-Dihydroindolyl-Sulfonamidverbindungen, deren Herstellung und Verwendung in Medikamenten |
| EP2487159A1 (de) | 2011-02-11 | 2012-08-15 | MSD Oss B.V. | RORgammaT-Hemmer |
| WO2014026327A1 (en) | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof |
| WO2014026330A1 (en) * | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
| WO2014026329A1 (en) | 2012-08-15 | 2014-02-20 | Merck Sharp & Dohme Corp. | N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof |
| CA2975997A1 (en) | 2015-02-11 | 2016-08-18 | Merck Sharp & Dohme Corp. | Substituted pyrazole compounds as rorgammat inhibitors and uses thereof |
| JP2018531958A (ja) | 2015-10-27 | 2018-11-01 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | ＲＯＲγＴ阻害薬としてのヘテロアリール置換安息香酸及びその使用 |
| CA3002850A1 (en) | 2015-10-27 | 2017-05-04 | Merck Sharp & Dohme Corp. | Substituted indazole compounds as rorgammat inhibitors and uses thereof |
| AU2016344111A1 (en) | 2015-10-27 | 2018-05-10 | Merck Sharp & Dohme Corp. | Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof |
| CA3107145A1 (en) | 2018-08-24 | 2020-02-27 | Sunshine Lake Pharma Co., Ltd. | Pyridinylmethylenepiperidine derivatives and uses thereof |
| EP3997081A1 (de) | 2019-07-11 | 2022-05-18 | Escape Bio, Inc. | Indazole und azaindazole als lrrk2-inhibitoren |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU198036B (en) * | 1983-08-22 | 1989-07-28 | Hoechst Roussel Pharma | Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them |
| US5776963A (en) * | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
| EP0494774A1 (de) * | 1991-01-11 | 1992-07-15 | MERCK SHARP & DOHME LTD. | Indazol-substituierte 5-Kettenglieder heteroaromatische Verbindungen |
| US5532240A (en) * | 1991-12-26 | 1996-07-02 | Yoshitomi Pharmaceutical Industries, Ltd. | Condensed thiophene compound and pharmaceutical use thereof |
| DK60793D0 (da) * | 1993-05-26 | 1993-05-26 | Novo Nordisk As | Kemiske forbindelser, deres fremstilling og anvendelse |
| CN1184425A (zh) * | 1995-03-20 | 1998-06-10 | 伊莱利利公司 | 5－取代－3－(1,2,3,6－四氢吡啶－4－基)－和3－(哌啶－4－基)－1h－吲哚:新型5－ht1f激动剂 |
| AU3261097A (en) * | 1996-06-21 | 1998-01-14 | Glaxo Group Limited | Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders |
| US5792763A (en) * | 1996-10-08 | 1998-08-11 | Eli Lilly And Company | Serotonin 5-HT1F agonists |
| ZA979961B (en) * | 1996-11-15 | 1999-05-05 | Lilly Co Eli | 5-HT1F agonists |
| EP0875513A1 (de) * | 1997-04-14 | 1998-11-04 | Eli Lilly And Company | Substituierte heteroaromatische 5-HT1F Agoniste |
-
1999
- 1999-06-16 US US09/334,157 patent/US6133290A/en not_active Expired - Fee Related
- 1999-06-22 AU AU46961/99A patent/AU4696199A/en not_active Abandoned
- 1999-06-22 WO PCT/US1999/013834 patent/WO2000006173A1/en not_active Ceased
- 1999-07-26 EP EP99305915A patent/EP0978514B1/de not_active Expired - Lifetime
- 1999-07-26 AT AT99305915T patent/ATE284879T1/de not_active IP Right Cessation
- 1999-07-26 DE DE69922594T patent/DE69922594T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000006173A8 (en) | 2000-04-06 |
| US6133290A (en) | 2000-10-17 |
| DE69922594D1 (de) | 2005-01-20 |
| WO2000006173A1 (en) | 2000-02-10 |
| AU4696199A (en) | 2000-02-21 |
| EP0978514A1 (de) | 2000-02-09 |
| EP0978514B1 (de) | 2004-12-15 |
| DE69922594T2 (de) | 2005-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69912279D1 (de) | 5-ht1f agonisten | |
| DE69922594D1 (de) | Indazol-Derivate als 5-HT1F agonists | |
| ATE377000T1 (de) | 5-ht1f agonisten | |
| BR9904998A (pt) | Derivados de hidroxamida do ácido 5-oxo-pirrolidina-2-carboxìlico | |
| DE69615674D1 (de) | Cyclobutan-derivate als inhibitoren der squalen-synthase und der protein farnesyltransferase | |
| DE60032780D1 (de) | Tetrahydroquinolin-derivate | |
| CY1112024T1 (el) | Αναστολεις υποδοχεων adp αιμοπεταλιων | |
| EE200100558A (et) | Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine | |
| EA200100203A1 (ru) | Производные 4,4-биарилпиперидина с активностью в отношении опиоидных рецепторов | |
| MXPA05000708A (es) | Derivados de quinolina 8-hidroxi. | |
| DE60012751D1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
| EP0976748A4 (de) | Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben | |
| ATE278661T1 (de) | Anthranilsäurederivate | |
| WO2000000490A3 (en) | 5-ht1f agonists | |
| NO985518L (no) | Morfinanderivater og medisinsk anvendelse derav | |
| PE20011085A1 (es) | Compuestos isoxazolquinolin o imidazolquinolin como inhibidores de la proteina resistente a multifarmacos | |
| EA200100918A1 (ru) | Агонисты 5-ht1f рецептора | |
| DE60002558D1 (de) | Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B | |
| TR200103561T2 (tr) | Rodanin türevleri ve amiloidlerin önlenmesi ve görüntülenmesinde kullanımları | |
| TR200103562T2 (tr) | Amiloid proteini toplanmasını önleme ve amiloid birikintilerini görüntüleme yönteminde kullanım için rodanin türevleri | |
| DE69231244D1 (de) | Pyrazolothiazolopyrimidin-derivate | |
| ID26809A (id) | Senyawa-senyawa turunan sianoiminokuinoksalin | |
| BR9604914A (pt) | Inibidores de agregaçao de plaquetas contendo resíduos de aminoácido de cadeia lateral aminérgicos c-terminais | |
| ECSP003360A (es) | Antagonistas de 5 - ht (caso x-11818) | |
| BR9915898A (pt) | Compostos, composição farmacêutica, e, utilização de um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |